Back
ESC Premium Access

Comparison of residual added index with residual sYNTAX score in the risk stratification of patients with incomplete coronary percutaneous revascularization after ST-elevation myocardial infarction

Session: Poster Session 7 - Risk scores at coronary revascularisation
Topic: Primary Percutaneous Coronary Intervention (PCI)
Speaker: Doctor L. Di Serafino (Naples, IT)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Luigi Di Serafino

AOU Federico II University of Naples, Naples (Italy)
0 follower

9 more presentations in this session

Syntax-Score II Based Assessment for role of complete revascularization by using percutaneous coronary intervention among Patients with Chronic Total Occlusion

Speaker: Doctor M. Shiba (Tokyo, JP)

Access
Abstract
Like
Thumbnail

Enhanced bedside PCI risk score predicting major adverse cardiovascular events

Speaker: Doctor L. Wang (Singapore, SG)

Access
Abstract
Slides
Like
Thumbnail

Validation of an NCDR-score-based risk model for cardiac catheterization procedures in a european population

Speaker: Doctor M. Brockmeyer (Duesseldorf, DE)

Access
Abstract
Slides
Like
Thumbnail

The ARDVAARC study: real-world outcomes and the utility of bleeding risk scores in patients who require anticoagulation following percutaneous coronary intervention (PCI)

Speaker: Doctor M. Li Kam Wa (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Utility of SYNTAX score II in revascularization decision-making process in patients with acute coronary syndrome without local heart surgery facilities

Speaker: Doctor F. Abcha (Tunis, TN)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 7 - Risk scores at coronary revascularisation

Speakers: Doctor L. Di Serafino, Doctor M. Shiba, Doctor L. Wang, Doctor M. Brockmeyer, Doctor M. Li Kam Wa...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources